So apparently only the vaccinated can enter this gym, yet it is the source of an outbreak. If only there was a booster, because you know…..
According to a report from the United Kingdom, it appears that the Covid-19 vaccine inhibits the body’s ability to naturally produce antibodies making vaccinated people more susceptible to catching the virus.
The information can be found in the UK Government’s most recent, Covid-19 Vaccine Surveillance Report. The report states that “N antibody levels appear to be lower in people who acquire infection following two doses of vaccination.” According to vaccine researcher Alex Berenson, this essentially means that vaccinated people who have become infected will never acquire complete immunity to the coronavirus.
“If they have this low [immunity] and it stays, and it persists… and that adaptive immune system response persists… it’s going to have a bad response to any other kind of viral infection. If you looked at that blood work, would you say that this person is very susceptible to having another viral infection, and maybe…you just might call it a breakthrough infection, you guys see that? A breakthrough infection. Could it be that after this maybe this is happening in a lot of people and leaving them wide open to have breakthrough infections after that?” – Dr. Nathan Thompson
By Jack Davis
September 16, 2021 at 4:07pm
As if a day with 166,284 news coronavirus cases and 2,678 deaths from COVID-19 were not bad enough, a report has now emerged that the protection offered by one of the major vaccines used in the United States declines quickly.
“The first six months are great, but you can’t count on that being stable out to a year and beyond,” Moderna President Stephen Hoge said on a conference call with investors, according to Reuters.
Moderna said in a news release that there was a 36 percentage point difference in the rate of breakthrough infections between those who were vaccinated roughly 13 months ago and those vaccinated roughly eight months ago.
“The increased risk of breakthrough in this analysis quantifies the impact of waning immunity,” Moderna said, adding that the falloff in protection comes “between the median follow-up time of 8 months and 13 months since first dose. The Company believes this adds to evidence of potential benefit of a booster dose.”
“Manuscripts summarizing both findings have been posted to preprint servers and will be submitted for peer-reviewed publication,” the company said.